Asia Pacific Biohacking Market Size & Outlook, 2021-2028

The biohacking market in Asia Pacific is expected to reach a projected revenue of US$ 14,820.7 billion by 2028. A compound annual growth rate of 20.5% is expected of Asia Pacific biohacking market from 2022 to 2028.
Revenue, 2021 (US$B)
$4,019.5
Forecast, 2028 (US$B)
$14,820.7
CAGR, 2022 - 2028
20.5%
Report Coverage
Asia Pacific

Asia Pacific biohacking market highlights

  • The Asia Pacific biohacking market generated a revenue of USD 4,019.5 billion in 2021.
  • The market is expected to grow at a CAGR of 20.5% from 2022 to 2028.
  • In terms of segment, wearables was the largest revenue generating product in 2021.
  • Smart Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2022 to 2028.


Asia Pacific data book summary

Market revenue in 2021USD 4,019.5 billion
Market revenue in 2028USD 14,820.7 billion
Growth rate20.5% (CAGR from 2021 to 2028)
Largest segmentWearables
Fastest growing segmentSmart Drugs
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD billion
Market segmentationWearables, Implants (Chips), Gene Modification Kits, Smart Drugs, Supplements, Mobile Apps
Key market players worldwideApple Inc, Fitbit, Harvey Norman Holdings Ltd, The ODIN, Thync, Moodmetric, Thriveport, TrackMyStack, OsteoStrong San Jose


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.8% of the global biohacking market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 14,820.7 billion by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biohacking Market Scope

Biohacking market segmentation & scope
Wearables
Implants (Chips)
Gene Modification Kits
Smart Drugs
Supplements
Mobile Apps
Others
Monitoring
Treatment
Research
Others
Pharmaceutical & Biotechnology Companies
Hospitals & Clinics
Forensic Laboratories
Research & Academic Institutes
Others

Biohacking Market Companies

Name Profile # Employees HQ Website

Asia Pacific biohacking market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biohacking market will help companies and investors design strategic landscapes.


Wearables was the largest segment with a revenue share of 17.98% in 2021. Horizon Databook has segmented the Asia Pacific biohacking market based on wearables, implants (chips), gene modification kits, smart drugs, supplements, mobile apps covering the revenue growth of each sub-segment from 2018 to 2028.


Reasons to subscribe to Asia Pacific biohacking market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific biohacking market databook

  • Our clientele includes a mix of biohacking market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biohacking market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biohacking market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific biohacking market size, by country, 2018-2028 (US$B)

Asia Pacific Biohacking Market Outlook Share, 2021 & 2028 (US$B)

Asia Pacific biohacking market size, by country, 2018-2028 (US$B)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more